These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38796871)

  • 1. Beyond transparency: Unpacking the financial effects of third-party environmental disclosure in China's semiconductor sector.
    Dagestani AA; Alnafrah I; Ding CJ; Qing L
    J Environ Manage; 2024 Jun; 360():121237. PubMed ID: 38796871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can environmental information disclosure spur corporate green innovation?
    Feng E; Siu YL; Wong CWY; Li S; Miao X
    Sci Total Environ; 2024 Feb; 912():169076. PubMed ID: 38052390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental information disclosure and corporate performance: Evidence from Chinese listed companies.
    Ye Y; Yang X; Shi L
    Heliyon; 2023 Dec; 9(12):e22400. PubMed ID: 38076146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From ambiguity to transparency: influence of environmental information disclosure on financial performance in the context of internationalization.
    Wang G; Du Q; Li X; Deng X; Niu Y
    Environ Sci Pollut Res Int; 2023 Jan; 30(4):10226-10244. PubMed ID: 36070037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Corporate Environmental Information Disclosure Falsification Based on Support Vector Machine.
    Li Y; Cai X; Sun H; He X
    Comput Intell Neurosci; 2022; 2022():5270963. PubMed ID: 36017454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do financial performance and firm's value affect the quality of corporate social responsibility disclosure: Moderating role of chief executive officer's power in China.
    Na C; Tian G; Rauf F; Naveed K
    Front Psychol; 2022; 13():925323. PubMed ID: 36059787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can semi-mandatory non-financial disclosure requirements drive firms to improve ESG performance - evidence from Chinese listed companies.
    Wu L; Lam JFI; Liu Y
    Heliyon; 2024 Jul; 10(14):e34235. PubMed ID: 39113963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of EID policy and trade on the environmental effects of Chinese paper enterprises from the perspective of financial constraints.
    Feng S; He D; Chen K
    Environ Res; 2024 Apr; 247():118170. PubMed ID: 38215921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental Regulation, Corporate Social Responsibility (CSR) Disclosure and Enterprise Green Innovation: Evidence from Listed Companies in China.
    Xu X; Jing R; Lu F
    Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Will environmental information disclosure affect bank credit decisions and corporate debt financing costs? Evidence from China's heavily polluting industries.
    Du M; Chai S; Wei W; Wang S; Li Z
    Environ Sci Pollut Res Int; 2022 Jul; 29(31):47661-47672. PubMed ID: 35184238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of ownership structure on environmental information disclosure: Evidence from China.
    Wei M; Wang Y; Giamporcaro S
    J Environ Manage; 2024 Feb; 352():120100. PubMed ID: 38266519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of investor attention and executive green awareness on environmental information disclosure of Chinese high-tech listed companies.
    Chen Y; Masron TA; Mai W
    J Environ Manage; 2024 Aug; 365():121552. PubMed ID: 38905790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nexus of the CSR disclosures and corporate financial performance: evidence from Asian countries climate policy uncertainty.
    Waris M; Din BH
    Environ Sci Pollut Res Int; 2024 Jan; 31(2):1995-2008. PubMed ID: 38049691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corporate environmental information disclosure and tax avoidance: Evidence from China.
    Gu Y; Wang S
    Heliyon; 2023 Nov; 9(11):e21492. PubMed ID: 38027798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Executive pharmaceutical background, R&D investment and corporate innovation performance.
    Zhang L; Li S; Wu M
    Am J Transl Res; 2023; 15(11):6576-6586. PubMed ID: 38074834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of expected financial performance on corporate environmental responsibility disclosure: evidence from China.
    Zeng Y; Gulzar MA; Wang Z; Zhao X
    Environ Sci Pollut Res Int; 2020 Oct; 27(30):37946-37962. PubMed ID: 32613511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can environmental information disclosure promote the high-quality development of enterprises? The mediating effect of intellectual capital.
    Jiang Y; Guo C; Wu Y
    Environ Sci Pollut Res Int; 2021 Jun; 28(24):30743-30757. PubMed ID: 33594551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trend and relationship between environmental accounting disclosure and environmental performance for mining companies listed in China.
    Agyemang AO; Yusheng K; Twum AK; Ayamba EC; Kongkuah M; Musah M
    Environ Dev Sustain; 2021; 23(8):12192-12216. PubMed ID: 33424427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Air Pollution and Corporate Green Financial Constraints: Evidence from China's Listed Companies.
    Shen Y; Lyu M; Zhu J
    Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of the quality of environmental information disclosure on financial performance: the moderating effect of internal and external stakeholders.
    Yang Y; Yang F; Zhao X
    Environ Sci Pollut Res Int; 2022 Sep; 29(45):68796-68814. PubMed ID: 35551596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.